GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Intercure Ltd (XTAE:INCR) » Definitions » Cyclically Adjusted Price-to-FCF

Intercure (XTAE:INCR) Cyclically Adjusted Price-to-FCF : (As of May. 08, 2024)


View and export this data going back to 2007. Start your Free Trial

What is Intercure Cyclically Adjusted Price-to-FCF?

Shiller PE for Stocks: The True Measure of Stock Valuation


Intercure Cyclically Adjusted Price-to-FCF Historical Data

The historical data trend for Intercure's Cyclically Adjusted Price-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Intercure Cyclically Adjusted Price-to-FCF Chart

Intercure Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted Price-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Intercure Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Dec23
Cyclically Adjusted Price-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Intercure's Cyclically Adjusted Price-to-FCF

For the Drug Manufacturers - Specialty & Generic subindustry, Intercure's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Intercure's Cyclically Adjusted Price-to-FCF Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Intercure's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Intercure's Cyclically Adjusted Price-to-FCF falls into.



Intercure Cyclically Adjusted Price-to-FCF Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted Price-to-FCF takes the Free Cash Flow per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/FCF calculation. Because it considers this 10-year average, it's often referred to as the CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF.

Intercure's Cyclically Adjusted FCF per Share for the quarter that ended in Jun. 2023 is calculated as:

For example, Intercure's adjusted Free Cash Flow per Share data for the three months ended in Jun. 2023 was:

Adj_FreeCashFlowPerShare=Free Cash Flow per Share/CPI of Jun. 2023 (Change)*Current CPI (Jun. 2023)
=0/128.7287*128.7287
=0.000

Current CPI (Jun. 2023) = 128.7287.

Intercure Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201209 -0.892 97.633 -1.176
201212 0.007 96.871 0.009
201303 -0.125 98.209 -0.164
201306 -0.121 98.518 -0.158
201309 -0.158 98.790 -0.206
201312 -0.017 98.326 -0.022
201403 -0.475 99.695 -0.613
201406 -0.108 100.560 -0.138
201409 -0.064 100.428 -0.082
201412 -0.018 99.070 -0.023
201503 -0.033 99.621 -0.043
201506 -0.019 100.684 -0.024
201509 -0.030 100.392 -0.038
201512 -0.057 99.792 -0.074
201603 0.001 100.470 0.001
201606 -0.046 101.688 -0.058
201609 -0.034 101.861 -0.043
201612 -0.015 101.863 -0.019
201706 0.000 103.349 0.000
201712 0.000 104.011 0.000
201806 0.000 106.317 0.000
201812 0.000 105.998 0.000
201903 -0.115 107.251 -0.138
201906 -0.588 108.070 -0.700
201909 -0.659 108.329 -0.783
201912 -0.295 108.420 -0.350
202003 -0.410 108.902 -0.485
202006 -0.383 108.767 -0.453
202009 0.062 109.815 0.073
202012 0.176 109.897 0.206
202103 0.183 111.754 0.211
202106 0.005 114.631 0.006
202109 0.183 115.734 0.204
202112 0.010 117.630 0.011
202203 -0.103 121.301 -0.109
202206 0.000 125.017 0.000
202209 0.000 125.227 0.000
202212 0.000 125.222 0.000
202303 -1.244 127.348 -1.257
202306 0.000 128.729 0.000

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Intercure  (XTAE:INCR) Cyclically Adjusted Price-to-FCF Explanation

Compared with the regular Price-to-Free-Cash-Flow, which works poorly for cyclical businesses, the Cyclically Adjusted Price-to-FCF smoothed out the fluctuations of free cash flow during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted Price-to-FCF should give similar results to regular Price-to-Free-Cash-Flow.


Intercure Cyclically Adjusted Price-to-FCF Related Terms

Thank you for viewing the detailed overview of Intercure's Cyclically Adjusted Price-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Intercure (XTAE:INCR) Business Description

Industry
Traded in Other Exchanges
Address
85 Medinat ha-Yehudim Street, Herzliya, ISR, 4676670
Intercure Ltd is engaged in the research, cultivation, production, and distribution of pharma-grade cannabis-based products. The products are distributed to hospitals, pharmacies, research, and government organizations.

Intercure (XTAE:INCR) Headlines

From GuruFocus

InterCure Announces the Withdrawal of a Class Action Lawsuit against it

By Value_Insider Value_Insider 12-05-2022